Structured evidence table for Riboflavin Fatigue Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Riboflavin Fatigue Randomized Trial | The etiology of fatigue in IBD is multifactorial and may be associated with inflammation, anemia, nutrient deficiencies, medications, and microbiota. | 4 | MORAIS Tayane (2026) | PHARMACOLOGICAL TREATMENTS FOR FATIGUE IN INFLAMMATORY BOWEL DISEASE PATIENTS: AN INTEGRATIVE REVIEW |
| Riboflavin Fatigue Randomized Trial | Fatigue in patients with IBD is associated with decreased physical functioning, mood disturbances, and low productivity, presenting symptoms of physical and mental exhaustion. | 4 | MORAIS Tayane (2026) | PHARMACOLOGICAL TREATMENTS FOR FATIGUE IN INFLAMMATORY BOWEL DISEASE PATIENTS: AN INTEGRATIVE REVIEW |
| Riboflavin Fatigue Randomized Trial | The guiding question for this study was: what is the current scientific evidence, over the last seven years, on the pharmacological treatment of fatigue in patients with IBD? | 4 | MORAIS Tayane (2026) | PHARMACOLOGICAL TREATMENTS FOR FATIGUE IN INFLAMMATORY BOWEL DISEASE PATIENTS: AN INTEGRATIVE REVIEW |
| Riboflavin Fatigue Randomized Trial | , , Inflammatory bowel disease (IBD) is a chronic inflammatory condition that results from the interaction between genetic and environmental factors that influence immune responses and one’s quality of life. | 4 | MORAIS Tayane (2026) | PHARMACOLOGICAL TREATMENTS FOR FATIGUE IN INFLAMMATORY BOWEL DISEASE PATIENTS: AN INTEGRATIVE REVIEW |
Source documents